nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—liver cancer	0.514	1	CbGaD
Cefazolin—ABCC4—Sorafenib—liver cancer	0.246	1	CbGbCtD
Cefazolin—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.00344	0.0262	CcSEcCtD
Cefazolin—Ceftriaxone—GLUL—liver cancer	0.003	0.423	CrCbGaD
Cefazolin—Blood bilirubin increased—Sorafenib—liver cancer	0.00278	0.0212	CcSEcCtD
Cefazolin—Mouth ulceration—Sorafenib—liver cancer	0.00238	0.0182	CcSEcCtD
Cefazolin—Prothrombin level increased—Epirubicin—liver cancer	0.00237	0.0181	CcSEcCtD
Cefazolin—Prothrombin level increased—Doxorubicin—liver cancer	0.0022	0.0167	CcSEcCtD
Cefazolin—Hepatic function abnormal—Sorafenib—liver cancer	0.00219	0.0167	CcSEcCtD
Cefazolin—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.0019	0.0145	CcSEcCtD
Cefazolin—Anorectal discomfort—Epirubicin—liver cancer	0.00178	0.0136	CcSEcCtD
Cefazolin—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.00176	0.0134	CcSEcCtD
Cefazolin—Local reaction—Epirubicin—liver cancer	0.00176	0.0134	CcSEcCtD
Cefazolin—Abdominal pain upper—Sorafenib—liver cancer	0.00175	0.0133	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00172	0.0131	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00172	0.0131	CcSEcCtD
Cefazolin—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.00168	0.0128	CcSEcCtD
Cefazolin—Anorectal discomfort—Doxorubicin—liver cancer	0.00165	0.0126	CcSEcCtD
Cefazolin—Local reaction—Doxorubicin—liver cancer	0.00163	0.0124	CcSEcCtD
Cefazolin—Thrombocytosis—Epirubicin—liver cancer	0.00157	0.0119	CcSEcCtD
Cefazolin—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.00155	0.0118	CcSEcCtD
Cefazolin—Neutropenia—Sorafenib—liver cancer	0.00155	0.0118	CcSEcCtD
Cefazolin—Oral candidiasis—Epirubicin—liver cancer	0.00153	0.0117	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00146	0.0111	CcSEcCtD
Cefazolin—Thrombocytosis—Doxorubicin—liver cancer	0.00145	0.011	CcSEcCtD
Cefazolin—Renal failure—Sorafenib—liver cancer	0.00145	0.011	CcSEcCtD
Cefazolin—Stomatitis—Sorafenib—liver cancer	0.00144	0.011	CcSEcCtD
Cefazolin—Oral candidiasis—Doxorubicin—liver cancer	0.00142	0.0108	CcSEcCtD
Cefazolin—Haemoglobin—Sorafenib—liver cancer	0.00133	0.0101	CcSEcCtD
Cefazolin—Haemorrhage—Sorafenib—liver cancer	0.00132	0.0101	CcSEcCtD
Cefazolin—Erythema multiforme—Sorafenib—liver cancer	0.00125	0.00954	CcSEcCtD
Cefazolin—Blood disorder—Epirubicin—liver cancer	0.00117	0.00889	CcSEcCtD
Cefazolin—Jaundice cholestatic—Epirubicin—liver cancer	0.00111	0.00845	CcSEcCtD
Cefazolin—Blood disorder—Doxorubicin—liver cancer	0.00108	0.00822	CcSEcCtD
Cefazolin—Anaemia—Sorafenib—liver cancer	0.00106	0.00811	CcSEcCtD
Cefazolin—Syncope—Sorafenib—liver cancer	0.00103	0.00787	CcSEcCtD
Cefazolin—Leukopenia—Sorafenib—liver cancer	0.00103	0.00786	CcSEcCtD
Cefazolin—Blood bilirubin increased—Epirubicin—liver cancer	0.00103	0.00785	CcSEcCtD
Cefazolin—Jaundice cholestatic—Doxorubicin—liver cancer	0.00103	0.00782	CcSEcCtD
Cefazolin—Creatinine increased—Epirubicin—liver cancer	0.00102	0.0078	CcSEcCtD
Cefazolin—Loss of consciousness—Sorafenib—liver cancer	0.00101	0.00772	CcSEcCtD
Cefazolin—Vaginal inflammation—Epirubicin—liver cancer	0.000974	0.00742	CcSEcCtD
Cefazolin—Blood bilirubin increased—Doxorubicin—liver cancer	0.000952	0.00726	CcSEcCtD
Cefazolin—Creatinine increased—Doxorubicin—liver cancer	0.000946	0.00721	CcSEcCtD
Cefazolin—Anaphylactic shock—Sorafenib—liver cancer	0.00094	0.00716	CcSEcCtD
Cefazolin—Colitis—Epirubicin—liver cancer	0.000935	0.00713	CcSEcCtD
Cefazolin—Candida infection—Epirubicin—liver cancer	0.000929	0.00709	CcSEcCtD
Cefazolin—Shock—Sorafenib—liver cancer	0.000925	0.00705	CcSEcCtD
Cefazolin—Thrombocytopenia—Sorafenib—liver cancer	0.00092	0.00701	CcSEcCtD
Cefazolin—Blood urea increased—Epirubicin—liver cancer	0.000919	0.00701	CcSEcCtD
Cefazolin—Vaginal infection—Epirubicin—liver cancer	0.000919	0.00701	CcSEcCtD
Cefazolin—Aplastic anaemia—Epirubicin—liver cancer	0.000914	0.00697	CcSEcCtD
Cefazolin—Vaginal inflammation—Doxorubicin—liver cancer	0.000901	0.00687	CcSEcCtD
Cefazolin—Anorexia—Sorafenib—liver cancer	0.000896	0.00683	CcSEcCtD
Cefazolin—Mouth ulceration—Epirubicin—liver cancer	0.00088	0.00671	CcSEcCtD
Cefazolin—Cefotetan—ALB—liver cancer	0.000879	0.124	CrCbGaD
Cefazolin—Colitis—Doxorubicin—liver cancer	0.000865	0.00659	CcSEcCtD
Cefazolin—Candida infection—Doxorubicin—liver cancer	0.00086	0.00656	CcSEcCtD
Cefazolin—Hypertonia—Epirubicin—liver cancer	0.000853	0.00651	CcSEcCtD
Cefazolin—Blood urea increased—Doxorubicin—liver cancer	0.00085	0.00648	CcSEcCtD
Cefazolin—Vaginal infection—Doxorubicin—liver cancer	0.00085	0.00648	CcSEcCtD
Cefazolin—Aplastic anaemia—Doxorubicin—liver cancer	0.000846	0.00645	CcSEcCtD
Cefazolin—Dyspepsia—Sorafenib—liver cancer	0.000827	0.00631	CcSEcCtD
Cefazolin—Phlebitis—Epirubicin—liver cancer	0.00082	0.00625	CcSEcCtD
Cefazolin—Decreased appetite—Sorafenib—liver cancer	0.000817	0.00623	CcSEcCtD
Cefazolin—Mouth ulceration—Doxorubicin—liver cancer	0.000814	0.00621	CcSEcCtD
Cefazolin—Fatigue—Sorafenib—liver cancer	0.00081	0.00618	CcSEcCtD
Cefazolin—Hepatic function abnormal—Epirubicin—liver cancer	0.000809	0.00616	CcSEcCtD
Cefazolin—Pain—Sorafenib—liver cancer	0.000804	0.00613	CcSEcCtD
Cefazolin—Hypertonia—Doxorubicin—liver cancer	0.00079	0.00602	CcSEcCtD
Cefazolin—Gastrointestinal pain—Sorafenib—liver cancer	0.000768	0.00586	CcSEcCtD
Cefazolin—Cefpiramide—ALB—liver cancer	0.000765	0.108	CrCbGaD
Cefazolin—Phlebitis—Doxorubicin—liver cancer	0.000759	0.00579	CcSEcCtD
Cefazolin—Hepatic function abnormal—Doxorubicin—liver cancer	0.000748	0.0057	CcSEcCtD
Cefazolin—Urticaria—Sorafenib—liver cancer	0.000747	0.00569	CcSEcCtD
Cefazolin—Abdominal pain—Sorafenib—liver cancer	0.000743	0.00566	CcSEcCtD
Cefazolin—Body temperature increased—Sorafenib—liver cancer	0.000743	0.00566	CcSEcCtD
Cefazolin—Hypersensitivity—Sorafenib—liver cancer	0.000692	0.00528	CcSEcCtD
Cefazolin—Asthenia—Sorafenib—liver cancer	0.000674	0.00514	CcSEcCtD
Cefazolin—Cefonicid—ALB—liver cancer	0.000666	0.0937	CrCbGaD
Cefazolin—Pruritus—Sorafenib—liver cancer	0.000665	0.00507	CcSEcCtD
Cefazolin—Blood creatinine increased—Epirubicin—liver cancer	0.000662	0.00505	CcSEcCtD
Cefazolin—Abdominal pain upper—Epirubicin—liver cancer	0.000645	0.00492	CcSEcCtD
Cefazolin—Diarrhoea—Sorafenib—liver cancer	0.000643	0.0049	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000636	0.00485	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000636	0.00485	CcSEcCtD
Cefazolin—Dizziness—Sorafenib—liver cancer	0.000621	0.00474	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—liver cancer	0.000613	0.00467	CcSEcCtD
Cefazolin—Eosinophilia—Epirubicin—liver cancer	0.000605	0.00461	CcSEcCtD
Cefazolin—Vomiting—Sorafenib—liver cancer	0.000598	0.00456	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—liver cancer	0.000597	0.00455	CcSEcCtD
Cefazolin—Rash—Sorafenib—liver cancer	0.000593	0.00452	CcSEcCtD
Cefazolin—Dermatitis—Sorafenib—liver cancer	0.000592	0.00451	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000589	0.00449	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000589	0.00449	CcSEcCtD
Cefazolin—Headache—Sorafenib—liver cancer	0.000589	0.00449	CcSEcCtD
Cefazolin—Cefmetazole—ALB—liver cancer	0.000586	0.0825	CrCbGaD
Cefazolin—Pancytopenia—Epirubicin—liver cancer	0.00058	0.00442	CcSEcCtD
Cefazolin—Neutropenia—Epirubicin—liver cancer	0.000571	0.00435	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—liver cancer	0.00056	0.00427	CcSEcCtD
Cefazolin—Nausea—Sorafenib—liver cancer	0.000558	0.00426	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00054	0.00412	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—liver cancer	0.000537	0.00409	CcSEcCtD
Cefazolin—Renal failure—Epirubicin—liver cancer	0.000535	0.00408	CcSEcCtD
Cefazolin—Stomatitis—Epirubicin—liver cancer	0.000531	0.00405	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—liver cancer	0.000528	0.00403	CcSEcCtD
Cefazolin—Agranulocytosis—Epirubicin—liver cancer	0.000508	0.00387	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.0005	0.00381	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—liver cancer	0.000495	0.00378	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—liver cancer	0.000491	0.00375	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—liver cancer	0.000491	0.00374	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—liver cancer	0.000489	0.00373	CcSEcCtD
Cefazolin—Hepatitis—Epirubicin—liver cancer	0.000489	0.00373	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—liver cancer	0.00047	0.00358	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—liver cancer	0.000462	0.00352	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—liver cancer	0.000455	0.00347	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—liver cancer	0.000452	0.00345	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—liver cancer	0.000452	0.00345	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—liver cancer	0.000428	0.00326	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—liver cancer	0.000419	0.0032	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—liver cancer	0.000393	0.003	CcSEcCtD
Cefazolin—Cefoperazone—ALB—liver cancer	0.000393	0.0552	CrCbGaD
Cefazolin—Agitation—Epirubicin—liver cancer	0.000391	0.00298	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—liver cancer	0.000388	0.00296	CcSEcCtD
Cefazolin—Syncope—Epirubicin—liver cancer	0.000382	0.00291	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—liver cancer	0.000381	0.0029	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—liver cancer	0.000374	0.00285	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—liver cancer	0.000369	0.00281	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—liver cancer	0.000364	0.00277	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—liver cancer	0.000362	0.00276	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—liver cancer	0.000353	0.00269	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—liver cancer	0.000352	0.00269	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—liver cancer	0.00035	0.00267	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—liver cancer	0.000347	0.00265	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—liver cancer	0.000346	0.00264	CcSEcCtD
Cefazolin—Shock—Epirubicin—liver cancer	0.000342	0.00261	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—liver cancer	0.000341	0.0026	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—liver cancer	0.00034	0.00259	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—liver cancer	0.000331	0.00252	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—liver cancer	0.000325	0.00247	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—liver cancer	0.000324	0.00247	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—liver cancer	0.000321	0.00245	CcSEcCtD
Cefazolin—Shock—Doxorubicin—liver cancer	0.000316	0.00241	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—liver cancer	0.000315	0.0024	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—liver cancer	0.000309	0.00235	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—liver cancer	0.000306	0.00234	CcSEcCtD
Cefazolin—Ceftriaxone—ALB—liver cancer	0.000306	0.043	CrCbGaD
Cefazolin—Dyspepsia—Epirubicin—liver cancer	0.000306	0.00233	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—liver cancer	0.000302	0.0023	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—liver cancer	0.0003	0.00229	CcSEcCtD
Cefazolin—Fatigue—Epirubicin—liver cancer	0.000299	0.00228	CcSEcCtD
Cefazolin—Pain—Epirubicin—liver cancer	0.000297	0.00226	CcSEcCtD
Cefazolin—Feeling abnormal—Epirubicin—liver cancer	0.000286	0.00218	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—liver cancer	0.000286	0.00218	CcSEcCtD
Cefazolin—Gastrointestinal pain—Epirubicin—liver cancer	0.000284	0.00217	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—liver cancer	0.000283	0.00216	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—liver cancer	0.000279	0.00213	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—liver cancer	0.000277	0.00211	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—liver cancer	0.000276	0.0021	CcSEcCtD
Cefazolin—Pain—Doxorubicin—liver cancer	0.000275	0.0021	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—liver cancer	0.000275	0.00209	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—liver cancer	0.000275	0.00209	CcSEcCtD
Cefazolin—Cefalotin—ALB—liver cancer	0.000268	0.0377	CrCbGaD
Cefazolin—Feeling abnormal—Doxorubicin—liver cancer	0.000265	0.00202	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000263	0.002	CcSEcCtD
Cefazolin—Hypersensitivity—Epirubicin—liver cancer	0.000256	0.00195	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—liver cancer	0.000255	0.00195	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—liver cancer	0.000254	0.00194	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—liver cancer	0.000254	0.00194	CcSEcCtD
Cefazolin—Asthenia—Epirubicin—liver cancer	0.000249	0.0019	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—GSTM1—liver cancer	0.000248	0.00243	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	0.000247	0.00242	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—liver cancer	0.000246	0.00241	CbGpPWpGaD
Cefazolin—Pruritus—Epirubicin—liver cancer	0.000246	0.00187	CcSEcCtD
Cefazolin—Cephalexin—ALB—liver cancer	0.000243	0.0342	CrCbGaD
Cefazolin—Diarrhoea—Epirubicin—liver cancer	0.000238	0.00181	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—liver cancer	0.000237	0.00181	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—ANXA2—liver cancer	0.000235	0.0023	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GLUL—liver cancer	0.000232	0.00227	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CPT1B—liver cancer	0.000232	0.00227	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000232	0.00227	CbGpPWpGaD
Cefazolin—Asthenia—Doxorubicin—liver cancer	0.000231	0.00176	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—MTHFR—liver cancer	0.00023	0.00225	CbGpPWpGaD
Cefazolin—Dizziness—Epirubicin—liver cancer	0.00023	0.00175	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—liver cancer	0.000227	0.00173	CcSEcCtD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.000227	0.00223	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NR1H4—liver cancer	0.000224	0.00219	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000222	0.00218	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000221	0.00217	CbGpPWpGaD
Cefazolin—Vomiting—Epirubicin—liver cancer	0.000221	0.00168	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—liver cancer	0.00022	0.00168	CcSEcCtD
Cefazolin—TPMT—Metabolism—GSTA3—liver cancer	0.00022	0.00215	CbGpPWpGaD
Cefazolin—Rash—Epirubicin—liver cancer	0.000219	0.00167	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—liver cancer	0.000219	0.00167	CcSEcCtD
Cefazolin—Headache—Epirubicin—liver cancer	0.000218	0.00166	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—liver cancer	0.000213	0.00162	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000212	0.00208	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000212	0.00208	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000212	0.00208	CbGpPWpGaD
Cefazolin—Nausea—Epirubicin—liver cancer	0.000206	0.00157	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—liver cancer	0.000204	0.00156	CcSEcCtD
Cefazolin—ALB—Selenium Micronutrient Network—GGT1—liver cancer	0.000204	0.002	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000203	0.00199	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000203	0.00199	CbGpPWpGaD
Cefazolin—Rash—Doxorubicin—liver cancer	0.000203	0.00154	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—liver cancer	0.000202	0.00154	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—F2—liver cancer	0.000202	0.00198	CbGpPWpGaD
Cefazolin—Headache—Doxorubicin—liver cancer	0.000201	0.00153	CcSEcCtD
Cefazolin—TPMT—Metabolism—GSTA4—liver cancer	0.000201	0.00197	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000201	0.00197	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000199	0.00195	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000198	0.00194	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000196	0.00193	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000196	0.00193	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTA2—liver cancer	0.000196	0.00192	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000194	0.0019	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000192	0.00188	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—IGF2—liver cancer	0.000192	0.00188	CbGpPWpGaD
Cefazolin—Nausea—Doxorubicin—liver cancer	0.000191	0.00146	CcSEcCtD
Cefazolin—TPMT—Metabolism—GSTA1—liver cancer	0.000189	0.00185	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000189	0.00185	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000188	0.00185	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—MTHFR—liver cancer	0.000187	0.00183	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NAT2—liver cancer	0.000187	0.00183	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000185	0.00181	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—liver cancer	0.000183	0.00179	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—HGF—liver cancer	0.000181	0.00178	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALDOB—liver cancer	0.000179	0.00176	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—VEGFA—liver cancer	0.000178	0.00175	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000178	0.00174	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000177	0.00173	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000177	0.00173	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000176	0.00172	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—liver cancer	0.000173	0.00169	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HBE1—liver cancer	0.000172	0.00169	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CRABP1—liver cancer	0.000171	0.00168	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	0.00017	0.00166	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SERPINE1—liver cancer	0.000168	0.00165	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000167	0.00164	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—F2—liver cancer	0.000164	0.00161	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—TGFB1—liver cancer	0.000163	0.0016	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	0.000156	0.00153	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINA1—liver cancer	0.000156	0.00152	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HPGDS—liver cancer	0.000149	0.00146	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—MTHFR—liver cancer	0.000149	0.00146	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000147	0.00144	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.000142	0.0014	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—F2—liver cancer	0.000138	0.00135	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—ALB—liver cancer	0.000138	0.00135	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SERPINE1—liver cancer	0.000137	0.00134	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINA1—liver cancer	0.000137	0.00134	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CYCS—liver cancer	0.000134	0.00131	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PSMA4—liver cancer	0.000133	0.00131	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PSMD10—liver cancer	0.000133	0.00131	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	0.000132	0.00129	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—CTNNB1—liver cancer	0.000131	0.00128	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—F2—liver cancer	0.00013	0.00128	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GOT2—liver cancer	0.00013	0.00127	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2E1—liver cancer	0.000122	0.00119	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SERPINE1—liver cancer	0.000117	0.00115	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000117	0.00114	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	0.000116	0.00114	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IFNA1—liver cancer	0.000116	0.00114	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	0.000115	0.00113	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—ALB—liver cancer	0.000115	0.00112	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYCS—liver cancer	0.000114	0.00112	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GGT1—liver cancer	0.000112	0.0011	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GOT1—liver cancer	0.000112	0.0011	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	0.000112	0.00109	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL2—liver cancer	0.000111	0.00108	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000109	0.00106	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ANXA2—liver cancer	0.000106	0.00104	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—liver cancer	0.000106	0.00104	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	0.000105	0.00103	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RAF1—liver cancer	0.000104	0.00102	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PRKCE—liver cancer	0.000102	0.001	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	0.000102	0.001	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	0.000101	0.000992	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—TGFB1—liver cancer	0.000101	0.00099	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000101	0.000986	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTP1—liver cancer	0.0001	0.000985	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HMOX1—liver cancer	9.91e-05	0.000971	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—liver cancer	9.9e-05	0.00097	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CYCS—liver cancer	9.8e-05	0.00096	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ABL1—liver cancer	9.75e-05	0.000956	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF2—liver cancer	9.71e-05	0.000952	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC40A1—liver cancer	9.6e-05	0.00094	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	9.49e-05	0.00093	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—PPARA—liver cancer	9.41e-05	0.000922	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IL2—liver cancer	9.3e-05	0.000911	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTM1—liver cancer	9.23e-05	0.000905	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP7B—liver cancer	9.2e-05	0.000902	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ANXA2—liver cancer	9.2e-05	0.000902	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HGF—liver cancer	9.17e-05	0.000899	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	9.15e-05	0.000897	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CSF2—liver cancer	9.07e-05	0.000889	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCE—liver cancer	9e-05	0.000882	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	8.89e-05	0.000871	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	8.76e-05	0.000859	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1A1—liver cancer	8.75e-05	0.000858	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NR1H4—liver cancer	8.7e-05	0.000853	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	8.53e-05	0.000836	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF2—liver cancer	8.52e-05	0.000835	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—HMOX1—liver cancer	8.52e-05	0.000835	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	8.3e-05	0.000813	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—liver cancer	8.16e-05	0.0008	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—liver cancer	8.06e-05	0.00079	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—liver cancer	8.06e-05	0.000789	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	8.05e-05	0.000789	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARA—liver cancer	8.01e-05	0.000785	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—liver cancer	7.99e-05	0.000783	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	7.96e-05	0.00078	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—liver cancer	7.9e-05	0.000774	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	7.68e-05	0.000752	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	7.42e-05	0.000727	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—liver cancer	7.4e-05	0.000725	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK14—liver cancer	7.34e-05	0.00072	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—liver cancer	7.25e-05	0.000711	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	7.18e-05	0.000704	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—F2—liver cancer	7.11e-05	0.000697	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—liver cancer	7.1e-05	0.000696	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	7.05e-05	0.000691	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINA1—liver cancer	7.04e-05	0.00069	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—liver cancer	7e-05	0.000686	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7e-05	0.000686	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UGDH—liver cancer	6.97e-05	0.000684	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—PPARA—liver cancer	6.88e-05	0.000674	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—liver cancer	6.86e-05	0.000672	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—liver cancer	6.81e-05	0.000667	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—liver cancer	6.62e-05	0.000649	CbGpPWpGaD
Cefazolin—ALB—Metabolism—EPT1—liver cancer	6.56e-05	0.000643	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—liver cancer	6.5e-05	0.000637	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	6.45e-05	0.000632	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—liver cancer	6.4e-05	0.000627	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—RAF1—liver cancer	6.33e-05	0.00062	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	6.25e-05	0.000612	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TAT—liver cancer	6.22e-05	0.000609	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	6.17e-05	0.000605	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.11e-05	0.000599	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—liver cancer	6.03e-05	0.000591	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	5.99e-05	0.000587	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—liver cancer	5.99e-05	0.000587	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	5.98e-05	0.000586	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—liver cancer	5.95e-05	0.000583	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—liver cancer	5.92e-05	0.00058	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—liver cancer	5.91e-05	0.000579	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RAF1—liver cancer	5.34e-05	0.000524	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	5.33e-05	0.000523	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	5.25e-05	0.000515	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—liver cancer	5.25e-05	0.000515	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA1—liver cancer	5.24e-05	0.000514	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—liver cancer	5.22e-05	0.000511	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	5.2e-05	0.000509	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—liver cancer	5.16e-05	0.000506	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	5.11e-05	0.000501	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	5.04e-05	0.000494	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	4.82e-05	0.000473	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—liver cancer	4.79e-05	0.00047	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	4.69e-05	0.00046	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCE—liver cancer	4.64e-05	0.000455	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	4.63e-05	0.000453	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	4.58e-05	0.000449	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.58e-05	0.000448	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	4.45e-05	0.000436	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	4.43e-05	0.000435	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ABL1—liver cancer	4.41e-05	0.000432	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF2—liver cancer	4.39e-05	0.000431	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GLUL—liver cancer	4.23e-05	0.000414	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CPT1B—liver cancer	4.23e-05	0.000414	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	4.21e-05	0.000412	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HGF—liver cancer	4.15e-05	0.000407	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CSF2—liver cancer	4.1e-05	0.000402	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NR1H4—liver cancer	4.07e-05	0.000399	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—liver cancer	4.07e-05	0.000399	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	4.03e-05	0.000395	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA3—liver cancer	4.01e-05	0.000393	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	3.85e-05	0.000378	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—liver cancer	3.74e-05	0.000366	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA4—liver cancer	3.66e-05	0.000359	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.58e-05	0.000351	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	3.57e-05	0.00035	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA2—liver cancer	3.57e-05	0.00035	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—liver cancer	3.46e-05	0.000339	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA1—liver cancer	3.44e-05	0.000338	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAT2—liver cancer	3.41e-05	0.000334	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK14—liver cancer	3.32e-05	0.000326	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	3.28e-05	0.000322	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.28e-05	0.000321	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDOB—liver cancer	3.27e-05	0.00032	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F2—liver cancer	3.22e-05	0.000316	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—liver cancer	3.2e-05	0.000314	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—liver cancer	3.18e-05	0.000312	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CRABP1—liver cancer	3.12e-05	0.000305	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	3.11e-05	0.000305	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—liver cancer	3.08e-05	0.000302	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—liver cancer	3.08e-05	0.000302	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—liver cancer	2.94e-05	0.000288	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.8e-05	0.000275	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.79e-05	0.000274	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPGDS—liver cancer	2.72e-05	0.000267	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—liver cancer	2.71e-05	0.000265	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.71e-05	0.000265	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—liver cancer	2.68e-05	0.000263	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—liver cancer	2.62e-05	0.000256	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—liver cancer	2.6e-05	0.000255	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.47e-05	0.000242	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSMD10—liver cancer	2.43e-05	0.000238	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSMA4—liver cancer	2.43e-05	0.000238	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAF1—liver cancer	2.42e-05	0.000237	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GOT2—liver cancer	2.36e-05	0.000231	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—liver cancer	2.36e-05	0.000231	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.28e-05	0.000224	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2E1—liver cancer	2.22e-05	0.000218	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—liver cancer	2.17e-05	0.000212	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.15e-05	0.000211	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	2.09e-05	0.000205	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYCS—liver cancer	2.08e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GGT1—liver cancer	2.04e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GOT1—liver cancer	2.04e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—liver cancer	1.84e-05	0.000181	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—liver cancer	1.83e-05	0.000179	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—liver cancer	1.81e-05	0.000177	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—liver cancer	1.69e-05	0.000166	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—liver cancer	1.68e-05	0.000165	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A1—liver cancer	1.59e-05	0.000156	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—liver cancer	1.57e-05	0.000154	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—liver cancer	1.49e-05	0.000146	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARA—liver cancer	1.46e-05	0.000143	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—liver cancer	1.44e-05	0.000141	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—liver cancer	1.39e-05	0.000136	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—liver cancer	1.33e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.31e-05	0.000128	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—liver cancer	1.25e-05	0.000122	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—liver cancer	1.21e-05	0.000118	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—liver cancer	1.18e-05	0.000115	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—liver cancer	1.1e-05	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—liver cancer	9.57e-06	9.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—liver cancer	5.83e-06	5.72e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—liver cancer	4.77e-06	4.67e-05	CbGpPWpGaD
